RxDoctor Payments Data

Thuyvi Pham

Family · Orange, CANPI 1558857359

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 177 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AstraZeneca at 36.3% of the total. Reporting peaked in 2021 at $3,149 and has fallen 99.0% since, to $30 in 2024. Among family clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,611in general payments, 2019–2025

Across 177 payments — averaging $20.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Vifor Pharma, Inc.$846
  • Amgen$252
  • Akebia Therapeutics Inc$220
  • Otsuka America Pharmaceutical, Inc.$188
  • GSK$172
  • plus $623 from 8 others

What the payments were for

  • Food & beverage$3,611100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,611 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.

See all family providers in California →

Other family in Orange

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →